Fluoxetine: Clinical Trials

60 trials of Fluoxetine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

38 completed, 8 terminated, 7 unknown, 4 recruiting. 60 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 460Completed 38, Terminated 8, Unknown 7, Recruiting 4, Not yet recruiting 2, Withdrawn 1

Follow Fluoxetine: new trials by email Literature Review of Fluoxetine trials Research Report on Fluoxetine

Trials (filtered) newest first · largest first

All 60 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria
Fluoxetine, Cognitive-behavioral therapy - Depression, HIV
Phase 4Not yet recruitingUniversity of Ibadan1682025-08-142025-08-08
Identifying and Treating Depression in the Orthopaedic Trauma Population
Fluoxetine 20 MG, Duloxetine 30 MG, Observation - Depression
Phase 4RecruitingWake Forest University Health Sciences1002025-06-252026-05-22
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
Fluoxetine, Escitalopram, Sertralin - Depression - Major Depressive Disorder, Depressive Episodes
Phase 4RecruitingPoznan University of Medical Sciences1802025-04-032026-03-18
Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in Bodily Trauma?
Fluoxetine, Placebo - Musculoskeletal Injury
Phase 4RecruitingUniversity of Florida2002024-03-012026-04-13
Efficacy of Hydroxyzine for Patients With Panic Disorder
Hydroxyzine, Escitalopram Oxalate - Panic Disorder
Phase 4Not yet recruitingSultan Qaboos University802023-12-302023-02-21
Fluoxetine Treatment of Depression in Down Syndrome
Fluoxetine - Down Syndrome, Depression
Phase 4CompletedMassachusetts General Hospital42022-12-052025-03-30
Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform
Problem Management Plus, Antidepressant Therapy - Depressive Disorder
Phase 4CompletedRAND4872021-09-012026-06-09
Fluoxetine to Reduce Intubation and Death After COVID19 Infection
Fluoxetine - COVID-19, Cytokine Storm
Phase 4CompletedUniversity of Toledo Health Science Campus162020-05-012024-06-07
Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
Vortioxetine, Sertraline, citalopram - Major Depressive Disorder
Phase 4CompletedAzienda Ospedaliera Universitaria Integrata Verona3622019-02-012023-05-19
Identifying and Treating Depression in Hemodialysis Patients
Fluoxetine - Depression, Hemodialysis-Induced Symptom
Phase 4CompletedMetroHealth Medical Center162018-03-012024-10-17
Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
Fluoxetine, fluoxetine + cognitive-behavioral treatment(CBT), fluoxetine + Amfebutamone - Depressive Disorder
Phase 4UnknownShanghai Mental Health Center8002017-08-012017-10-10
Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke
Fluoxetine, Placebo, fMRI - Stroke
Phase 4CompletedUniversity Hospital, Toulouse252017-02-272023-08-28
Bupropion for Depression in ESRD Patients on Hemodialysis
Fluoxetine, Bupropion - Major Depression, End Stage Renal Disease
Phase 4TerminatedUniversity of Arkansas12016-03-312018-07-17
Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.
Antidepressants, Positron Emission Tomography (PET) - Bulimia Nervosa
Phase 4CompletedCentre Hospitalier Universitaire de Saint Etienne512015-11-092022-11-30
16-week Comparative Effectiveness Trial of Lamotrigine vs. Fluoxetine for Bipolar Depression
Lamotrigine, Fluoxetine - Bipolar Disorder
Phase 4TerminatedMayo Clinic22015-03-012019-06-19
Prediction of Clinical Response to SSRI Treatment in Bipolar Disorder Using Serotonin 1A Receptor PET Imaging
Fluoxetine, Citalopram - Bipolar Disorder
Phase 4CompletedNew York State Psychiatric Institute402015-01-012024-12-31
Fluoxetine vs Aripiprazole Comparative Trial (FACT)
Aripiprazole, Fluoxetine - Attenuated Psychosis Syndrome
Phase 4TerminatedNorthwell Health92014-07-012023-11-15
Measurement-based Care for Depression in Resource-Poor Settings
Fluoxetine, Enhanced Usual Care - Major Depression
Phase 4CompletedFlorida International University1402014-02-012016-12-01
Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
Fluoxetine, Sertraline, Paroxetine - Obsessive-Compulsive Disorder, Anxiety Disorders
Phase 4CompletedShanghai Mental Health Center782014-01-012022-09-09
Effects of Treatment on Decision-making in Major Depression
Any FDA Approved Antidepressant - Major Depressive Disorder, Healthy Controls
Phase 4CompletedEmory University532013-08-012017-11-21

Showing 20 of 60. Sign in to see all of them.

Conditions studied

Depression (20)  ·  Depressive Disorder, Major (16)  ·  Bipolar Disorder (8)  ·  Obsessive-Compulsive Disorder (5)  ·  Depressive Disorder (4)  ·  Suicide (4)  ·  Alcoholism (3)  ·  Anxiety Disorders (2)  ·  Borderline Personality Disorder (2)  ·  Kidney Failure, Chronic (2)  ·  Self-Injurious Behavior (2)  ·  Alcohol-Related Disorders (1)  ·  Anorexia Nervosa (1)  ·  Body Dysmorphic Disorders (1)  ·  Breast Feeding (1)

Sponsors

New York State Psychiatric Institute (7)  ·  Eli Lilly and Company (3)  ·  Massachusetts General Hospital (3)  ·  Shanghai Mental Health Center (3)  ·  University of Pennsylvania (3)  ·  National Cheng-Kung University Hospital (2)  ·  University of California, Los Angeles (2)  ·  University of Florida (2)  ·  University of Sao Paulo (2)  ·  Wake Forest University Health Sciences (2)  ·  Azienda Ospedaliera Universitaria Integrata Verona (1)  ·  Capital Medical University (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Creighton University (1)

Countries

United States (33)  ·  China (5)  ·  France (3)  ·  Taiwan (3)  ·  Brazil (2)  ·  Israel (2)  ·  Germany (1)  ·  Ghana (1)  ·  Haiti (1)  ·  Italy (1)  ·  Malawi (1)  ·  Nigeria (1)  ·  Poland (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Alan Apter, MD (1)  ·  Allan Kaplan, MD (1)  ·  Andrew F Leuchter (1)  ·  Angela L Ofori-Atta, PhD (1)  ·  Ash Seghal, MD (1)  ·  B. Timothy Walsh, MD (1)  ·  Barbara H. Stanley, PhD (1)  ·  Barbara Stanley, PhD (1)  ·  Boadie W Dunlop, MD (1)  ·  Chantal Csajka, Prof PhD (1)  ·  Ching-Hua Lin, M.D. (1)  ·  Christoph Correll, MD (1)

Results publications

PMID 19578654, PMID 33884617, PMID 11806859, PMID 12874492, PMID 1438661, PMID 14627997, PMID 14639062, PMID 15729083, PMID 15910213, PMID 16086624, PMID 16772623, PMID 16946178, PMID 17014022, PMID 19574030, PMID 19593175, PMID 20187924, PMID 20360317, PMID 20478741, PMID 20579510, PMID 20726279, PMID 21095016, PMID 21447050, PMID 21601519, PMID 21672502, PMID 21907540, PMID 22020357, PMID 22027844, PMID 22116638, PMID 22273276, PMID 22334811, PMID 22841131, PMID 23099447, PMID 23132334, PMID 23948637, PMID 24552630, PMID 24995027, PMID 25080392, PMID 27984559, PMID 28577548, PMID 28841824, PMID 28900756, PMID 28915895, PMID 29355886, PMID 29433613, PMID 30561642, PMID 32162723, PMID 32368793, PMID 32746941, PMID 33116533, PMID 34011310

NIH funding

R01MH061017 (2), 2005 (1), 2015 (1), 2016 (1), 2018 (1), K43TW011995 (1), P20AA015630 (1), R01AR045416 (1), R01MH045802 (1), R01MH060271 (1), R01MH060336 (1), R01MH060353 (1), R01MH080097 (1), R01MH080098 (1), R01MH080270 (1)